At ARTIS, we've been fortunate over the past decade to have had a front-row seat at the accelerating convergence of frontier technologies and medicine. We have witnessed firsthand just how technological advancements in areas like artificial intelligence, machine learning, and synthetic biology have ushered in new generations of life-saving innovations and medicines. Diseases that once seemed unconquerable now have promising treatment options and even cures on the horizon. Cutting-edge companies are developing personalized therapies tailored to each patient's unique biology, finally moving beyond a one-size-fits-all approach. We are also gaining incredible new tools to understand the body, mind, and the connections between them as never before. The expertise of medical professionals is being augmented and enhanced through these advances. And the building blocks of biology are being harnessed to develop revolutionary new therapies and solutions. We call this all-important work and its convergence “TechBio” and we’re excited to continue to leverage our leadership role as a pioneer within the space to accelerate this revolution.
A decade ago, when AI was emerging, we saw its opportunity to transform human health and well-being by leveraging growing data sets, advanced analytics, and insights. And over the past decade, by harnessing the power of AI, our portfolio companies have pioneered innovations across clinical medicine, medical devices, computational biology, and more – fundamentally changing the quality of care and alleviating suffering globally.
Our TechBio investment process is guided by the following principles:
The age of TechBio brings with it tremendous hope and possibility. United by our common humanity and shared desire for health and well-being, we now have innovations at our fingertips that can alleviate suffering for millions. The future looks brighter than ever, and the only limit to progress is our imagination. If we dream it, we can achieve it.
ARTIS is proud to have been the first dedicated fund globally to deploy capital wherever data, software, AI, machine learning, and deep learning transform human health and well-being. The sky is the limit for how we can transform lives with the advances in technology and medicine. The best is yet to come!
Stuart Peterson & Vasudev Bailey, Managing Partners, ARTIS Ventures